Medical device manufacturer Integra LifeSciences Holdings Corp. was on the receiving end of a warning letter from the U.S. Food & Drug Administration last week, in which it was cited over concerns relating to process validations, corrective and preventative actions, as well as document controls, at its Añasco plant.
Less than four months after confirming plans to pick up the assets of the former Pfizer manufacturing plant in Caguas, Neolpharma officially inaugurated Tuesday its first operation on U.S. soil and the second established outside its native Mexico.
The Puerto Rico Justice Department has joined 19 other U.S. jurisdictions in an antitrust case filed by the Federal Trade Commission aimed at fighting monopolistic practices within the pharmaceutical industry that reportedly cost consumers about $3.5 billion per year in the form of higher drug prices.
Following a seven-month evaluation process, the Puerto Rico Manufacturers Association has named Economist and Attorney Jaime García as the trade group’s new executive director, effective Feb 1. He succeeds William Riefkohl, who announced in the summer he would be stepping down from the post after 15 years.
The biopharmaceutical industry is a major driver of Puerto Rico’s social and economic development, not just for the 86,000 direct and indirect jobs its creates, but for the multiplier effects it has upon other sectors.
Shooting down reports circulated Tuesday saying it planned to close its Guayama operation, pharmaceutical company Lilly del Caribe announced and launched a voluntary severance program for eligible employees working at the site.
Three years after entering the Puerto Rico market, Cousins International Food Corp., franchisees of the International House of Pancakes concept, better known as IHOP, has filed for Chapter 11 bankruptcy protection for its two restaurants in Caguas and Barceloneta.
Medical device manufacturer Edwards Lifesciences will be investing $34 million to expand its Añasco facility, creating 263 jobs and retaining 52 existing ones, company and government officials said Tuesday.
In 2011, Peter Paul Electric Inc. in Fajardo got a generous offer from the state of Connecticut to consolidate its Puerto Rico operation with that of its parent company’s in New Britain.
Mexico’s Neolpharma will be picking up the assets of Pfizer’s Caguas manufacturing plant, through an agreement that is expected to close during the first quarter of 2013, company executives announced Tuesday. The financial terms of the agreement were not disclosed.
Johnson & Johnson is expanding its presence in Puerto Rico through a $226.5 million investment that will improve its two plants in Gurabo and operations in Manatí and San Lorenzo, and add 308 new jobs to its payroll, company and government officials announced Monday.
To mark its 100 years of doing business worldwide, The Clorox Company recently completed a $2 million upgrade and expansion project at its manufacturing plant in Caguas.
Three months after announcing its decision to leave the island after 50 years of operations, Bumble Bee has hired San Diego-based Heritage Global Partners to auction off the assets of the former plant in Mayagüez, on Sept. 12 and 13. The sale will be conducted over the phone and online.
Merck Puerto Rico announced it will invest some $80 million over the next year to expand production capabilities at its Las Piedras manufacturing plant.
More than two years after running into some serious production troubles at its Las Piedras plant, McNeil Consumer Healthcare announced Tuesday it will layoff 225 people as it focuses on complying with correcting deficiencies detected by the U.S. Food and Drug Administration.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA